
Call:
glm(formula = y ~ `2021_WHO_Classification` * cluster_assigned, 
    family = poisson, data = anno_file)

Coefficients: (3 not defined because of singularities)
                                                                                          Estimate
(Intercept)                                                                                3.36730
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered                       -1.75786
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered                    0.32158
`2021_WHO_Classification`Ganglioglioma                                                    -0.14842
`2021_WHO_Classification`Glioneuronal and neuronal tumors                                 -2.26868
`2021_WHO_Classification`Myxoid glioneuronal tumor                                        -0.82668
`2021_WHO_Classification`Pilocytic astrocytoma                                             0.15906
`2021_WHO_Classification`Subependymal giant cell astrocytoma                              -0.96940
cluster_assigned1                                                                          0.24362
cluster_assigned2                                                                         -0.59471
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned1           NA
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned1  0.25715
`2021_WHO_Classification`Ganglioglioma:cluster_assigned1                                  -1.26527
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned1               -1.34223
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned1                      -1.17480
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned1                           0.67267
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned1            -0.69561
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned2     -0.32158
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned2  0.69002
`2021_WHO_Classification`Ganglioglioma:cluster_assigned2                                  -1.23787
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned2               -0.50391
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned2                            NA
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned2                           1.66347
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned2                  NA
                                                                                          Std. Error
(Intercept)                                                                                  0.03448
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered                          0.20295
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered                      0.04259
`2021_WHO_Classification`Ganglioglioma                                                       0.05281
`2021_WHO_Classification`Glioneuronal and neuronal tumors                                    0.33511
`2021_WHO_Classification`Myxoid glioneuronal tumor                                           0.15593
`2021_WHO_Classification`Pilocytic astrocytoma                                               0.04532
`2021_WHO_Classification`Subependymal giant cell astrocytoma                                 0.09723
cluster_assigned1                                                                            0.04381
cluster_assigned2                                                                            0.07138
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned1             NA
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned1    0.05267
`2021_WHO_Classification`Ganglioglioma:cluster_assigned1                                     0.12596
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned1                  1.05500
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned1                         0.25504
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned1                             0.05406
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned1               0.17491
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned2        0.54323
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned2    0.07897
`2021_WHO_Classification`Ganglioglioma:cluster_assigned2                                     0.26305
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned2                  1.05650
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned2                              NA
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned2                             0.07786
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned2                    NA
                                                                                          z value
(Intercept)                                                                                97.652
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered                        -8.661
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered                     7.550
`2021_WHO_Classification`Ganglioglioma                                                     -2.810
`2021_WHO_Classification`Glioneuronal and neuronal tumors                                  -6.770
`2021_WHO_Classification`Myxoid glioneuronal tumor                                         -5.302
`2021_WHO_Classification`Pilocytic astrocytoma                                              3.510
`2021_WHO_Classification`Subependymal giant cell astrocytoma                               -9.970
cluster_assigned1                                                                           5.561
cluster_assigned2                                                                          -8.331
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned1          NA
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned1   4.882
`2021_WHO_Classification`Ganglioglioma:cluster_assigned1                                  -10.045
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned1                -1.272
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned1                       -4.606
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned1                           12.442
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned1             -3.977
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned2      -0.592
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned2   8.737
`2021_WHO_Classification`Ganglioglioma:cluster_assigned2                                   -4.706
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned2                -0.477
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned2                           NA
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned2                           21.364
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned2                 NA
                                                                                          Pr(>|z|)
(Intercept)                                                                                < 2e-16
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered                        < 2e-16
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered                   4.34e-14
`2021_WHO_Classification`Ganglioglioma                                                    0.004948
`2021_WHO_Classification`Glioneuronal and neuronal tumors                                 1.29e-11
`2021_WHO_Classification`Myxoid glioneuronal tumor                                        1.15e-07
`2021_WHO_Classification`Pilocytic astrocytoma                                            0.000449
`2021_WHO_Classification`Subependymal giant cell astrocytoma                               < 2e-16
cluster_assigned1                                                                         2.69e-08
cluster_assigned2                                                                          < 2e-16
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned1           NA
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned1 1.05e-06
`2021_WHO_Classification`Ganglioglioma:cluster_assigned1                                   < 2e-16
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned1               0.203280
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned1                      4.10e-06
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned1                           < 2e-16
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned1            6.98e-05
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned2     0.553859
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned2  < 2e-16
`2021_WHO_Classification`Ganglioglioma:cluster_assigned2                                  2.53e-06
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned2               0.633393
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned2                            NA
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned2                           < 2e-16
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned2                  NA
                                                                                             
(Intercept)                                                                               ***
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered                       ***
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered                   ***
`2021_WHO_Classification`Ganglioglioma                                                    ** 
`2021_WHO_Classification`Glioneuronal and neuronal tumors                                 ***
`2021_WHO_Classification`Myxoid glioneuronal tumor                                        ***
`2021_WHO_Classification`Pilocytic astrocytoma                                            ***
`2021_WHO_Classification`Subependymal giant cell astrocytoma                              ***
cluster_assigned1                                                                         ***
cluster_assigned2                                                                         ***
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned1        
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned1 ***
`2021_WHO_Classification`Ganglioglioma:cluster_assigned1                                  ***
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned1                  
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned1                      ***
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned1                          ***
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned1            ***
`2021_WHO_Classification`Diffuse astrocytoma, MYB- or MYBL1-altered:cluster_assigned2        
`2021_WHO_Classification`Diffuse low-grade glioma, MAPK pathway-altered:cluster_assigned2 ***
`2021_WHO_Classification`Ganglioglioma:cluster_assigned2                                  ***
`2021_WHO_Classification`Glioneuronal and neuronal tumors:cluster_assigned2                  
`2021_WHO_Classification`Myxoid glioneuronal tumor:cluster_assigned2                         
`2021_WHO_Classification`Pilocytic astrocytoma:cluster_assigned2                          ***
`2021_WHO_Classification`Subependymal giant cell astrocytoma:cluster_assigned2               
---
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

(Dispersion parameter for poisson family taken to be 1)

    Null deviance: 1.0323e+04  on 529  degrees of freedom
Residual deviance: 1.0014e-12  on 509  degrees of freedom
AIC: 3018.4

Number of Fisher Scoring iterations: 3

